Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Amortization of Deferred Charges: 2022-2025

Historic Amortization of Deferred Charges for Neogen (NEOG) over the last 3 years, with Aug 2025 value amounting to $539,000.

  • Neogen's Amortization of Deferred Charges fell 37.33% to $539,000 in Q3 2025 from the same period last year, while for Aug 2025 it was $2.9 million, marking a year-over-year decrease of 15.78%. This contributed to the annual value of $3.2 million for FY2025, which is 6.45% down from last year.
  • Per Neogen's latest filing, its Amortization of Deferred Charges stood at $539,000 for Q3 2025, which was down 15.65% from $639,000 recorded in Q2 2025.
  • In the past 5 years, Neogen's Amortization of Deferred Charges ranged from a high of $861,000 in Q1 2024 and a low of $122,000 during Q4 2022.
  • Moreover, its 3-year median value for Amortization of Deferred Charges was $860,000 (2025), whereas its average is $743,727.
  • In the last 5 years, Neogen's Amortization of Deferred Charges surged by 605.74% in 2024 and then tumbled by 37.33% in 2025.
  • Quarterly analysis of 4 years shows Neogen's Amortization of Deferred Charges stood at $122,000 in 2022, then spiked by 604.92% to $860,000 in 2023, then remained steady at $860,000 in 2024, then tumbled by 37.33% to $539,000 in 2025.
  • Its Amortization of Deferred Charges was $539,000 in Q3 2025, compared to $639,000 in Q2 2025 and $860,000 in Q1 2025.